Opinion Article
The Use of Biosimilar Drugs in Psoriasis: A Position Paper
Fármacos biosimilares en psoriasis: informe de posicionamiento
Leído
6583
Vecesse ha leído el artículo
3104
Total PDF
3479
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 26 | 2 | 28 |
| 2025 5 | 140 | 35 | 175 |
| 2025 4 | 120 | 35 | 155 |
| 2025 3 | 107 | 32 | 139 |
| 2025 2 | 115 | 35 | 150 |
| 2025 1 | 71 | 36 | 107 |
| 2024 12 | 58 | 62 | 120 |
| 2024 11 | 91 | 65 | 156 |
| 2024 10 | 55 | 58 | 113 |
| 2024 9 | 58 | 35 | 93 |
| 2024 8 | 82 | 65 | 147 |
| 2024 7 | 76 | 49 | 125 |
| 2024 6 | 68 | 47 | 115 |
| 2024 5 | 54 | 29 | 83 |
| 2024 4 | 61 | 33 | 94 |
| 2024 3 | 55 | 33 | 88 |
| 2024 2 | 52 | 32 | 84 |
| 2024 1 | 36 | 47 | 83 |
| 2023 12 | 39 | 18 | 57 |
| 2023 11 | 45 | 29 | 74 |
| 2023 10 | 33 | 22 | 55 |
| 2023 9 | 47 | 34 | 81 |
| 2023 8 | 45 | 28 | 73 |
| 2023 7 | 38 | 62 | 100 |
| 2023 6 | 53 | 22 | 75 |
| 2023 5 | 55 | 31 | 86 |
| 2023 4 | 33 | 26 | 59 |
| 2023 3 | 27 | 32 | 59 |
| 2023 2 | 53 | 29 | 82 |
| 2022 1 | 29 | 19 | 48 |
| 2022 12 | 35 | 47 | 82 |
| 2022 11 | 22 | 33 | 55 |
| 2022 10 | 17 | 20 | 37 |
| 2022 9 | 22 | 33 | 55 |
| 2022 8 | 26 | 32 | 58 |
| 2022 7 | 19 | 33 | 52 |
| 2022 6 | 21 | 35 | 56 |
| 2022 5 | 46 | 56 | 102 |
| 2022 4 | 41 | 37 | 78 |
| 2022 3 | 54 | 42 | 96 |
| 2022 2 | 38 | 26 | 64 |
| 2021 1 | 38 | 43 | 81 |
| 2021 12 | 20 | 57 | 77 |
| 2021 11 | 41 | 60 | 101 |
| 2021 10 | 31 | 63 | 94 |
| 2021 9 | 38 | 32 | 70 |
| 2021 8 | 51 | 40 | 91 |
| 2021 7 | 26 | 26 | 52 |
| 2021 6 | 56 | 59 | 115 |
| 2021 5 | 34 | 20 | 54 |
| 2021 4 | 34 | 68 | 102 |
| 2021 3 | 76 | 25 | 101 |
| 2021 2 | 51 | 46 | 97 |
| 2020 1 | 36 | 29 | 65 |
| 2020 12 | 37 | 22 | 59 |
| 2020 11 | 28 | 33 | 61 |
| 2020 10 | 20 | 15 | 35 |
| 2020 9 | 37 | 15 | 52 |
| 2020 8 | 23 | 21 | 44 |
| 2020 7 | 17 | 21 | 38 |
| 2020 6 | 39 | 38 | 77 |
| 2020 5 | 18 | 33 | 51 |
| 2020 4 | 24 | 26 | 50 |
| 2020 3 | 22 | 22 | 44 |
| 2020 2 | 3 | 4 | 7 |
| 2020 1 | 0 | 5 | 5 |
| 2019 12 | 4 | 6 | 10 |
| 2019 11 | 0 | 2 | 2 |
| 2019 10 | 0 | 2 | 2 |
| 2019 9 | 6 | 3 | 9 |
| 2019 8 | 0 | 1 | 1 |
| 2019 7 | 0 | 13 | 13 |
| 2019 6 | 0 | 8 | 8 |
| 2019 5 | 2 | 72 | 74 |
| 2019 4 | 0 | 39 | 39 |
| 2019 3 | 0 | 11 | 11 |
| 2019 2 | 2 | 7 | 9 |
| 2019 1 | 0 | 4 | 4 |
| 2018 12 | 4 | 5 | 9 |
| 2018 11 | 2 | 3 | 5 |
| 2018 10 | 1 | 0 | 1 |
| 2018 9 | 6 | 2 | 8 |
| 2018 8 | 0 | 15 | 15 |
| 2018 7 | 0 | 7 | 7 |
| 2018 6 | 0 | 5 | 5 |
| 2018 5 | 0 | 12 | 12 |
| 2018 4 | 0 | 8 | 8 |
| 2018 3 | 1 | 11 | 12 |
| 2018 2 | 23 | 9 | 32 |
| 2018 1 | 38 | 14 | 52 |
| 2017 12 | 29 | 15 | 44 |
| 2017 11 | 24 | 18 | 42 |
| 2017 10 | 23 | 23 | 46 |
| 2017 9 | 12 | 20 | 32 |
| 2017 8 | 25 | 16 | 41 |
| 2017 7 | 19 | 22 | 41 |
| 2017 6 | 26 | 43 | 69 |
| 2017 5 | 19 | 23 | 42 |
| 2017 4 | 16 | 21 | 37 |
| 2017 3 | 12 | 56 | 68 |
| 2017 2 | 13 | 55 | 68 |
| 2016 1 | 17 | 28 | 45 |
| 2016 12 | 29 | 25 | 54 |
| 2016 11 | 31 | 35 | 66 |
| 2016 10 | 23 | 30 | 53 |
| 2016 9 | 0 | 15 | 15 |
| 2016 8 | 0 | 16 | 16 |
| 2016 7 | 11 | 12 | 23 |
| 2016 6 | 16 | 2 | 18 |
| 2016 5 | 11 | 24 | 35 |
| 2016 4 | 6 | 2 | 8 |
| 2016 3 | 4 | 2 | 6 |
| 2016 2 | 10 | 1 | 11 |
| 2015 1 | 7 | 1 | 8 |
| 2015 12 | 12 | 4 | 16 |
| 2015 11 | 8 | 3 | 11 |
| 2015 10 | 0 | 6 | 6 |
| 2015 9 | 0 | 2 | 2 |
| 2015 8 | 0 | 4 | 4 |
| 2015 7 | 8 | 1 | 9 |
| 2015 6 | 4 | 11 | 15 |
| 2015 5 | 12 | 10 | 22 |
Mostrar todo
